Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Mar 2013

Sullivan Lisa M, Folpe Andrew L, Pawel Bruce R, Judkins Alexander R, Biegel Jaclyn A

Abstract excerpt

SMARCB1 gene alterations were first described in highly malignant rhabdoid tumors of the kidney, brain (atypical teratoid/rhabdoid tumor) and soft tissue. An increasing number of tumors have now shown loss of SMARCB1 protein expression by immunohistochemistry, including the majority of epithelioid sarcomas. However, investigations of SMARCB1 gene alterations in epithelioid sarcoma have produced conflicting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomal Proteins, Non-Histone
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Minnesota

Share to Multiplex Polymerase Chain Reaction

Share to Predictive Value of Tests

Share to Sarcoma

Share to SMARCB1 Protein

Share to Soft Tissue Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23060122
DOI: 10.1038/modpathol.2012.175
PMCID: PMC3556344

Genes

SMARCB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.PMID 23060122Read ↗

Consistent <i>SMARCB1</i> homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival materialSemantic proximity Read ↗

Pathology and diagnosis of SMARCB1-deficient tumors.Semantic proximity Read ↗

SMARCB1 -deficient Tumors of Childhood: A Practical GuideSemantic proximity Read ↗

SMARCB1 / INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJSemantic proximity Read ↗

The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.Semantic proximity Read ↗

Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.Semantic proximity Read ↗

<i>SMARCB1/INI1</i> Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid SarcomasSemantic proximity Read ↗

Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumorSemantic proximity Read ↗

Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic NeoplasmsSemantic proximity Read ↗

SMARCB1-deficient Vulvar NeoplasmsSemantic proximity Read ↗

Prognostic determinants in epithelioid sarcoma.Semantic proximity Read ↗

Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.